• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国女性中低危型人乳头瘤病毒的流行率和血清流行率。

Prevalence and seroprevalence of low-risk human papillomavirus in Korean women.

机构信息

Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2012 Aug;27(8):922-8. doi: 10.3346/jkms.2012.27.8.922. Epub 2012 Jul 25.

DOI:10.3346/jkms.2012.27.8.922
PMID:22876060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3410241/
Abstract

Little is known about the prevalence and seroprevalence of low-risk human papillomavirus (HPV) and the risk factors for HPV infection in Korean women. We determined the prevalence of low-risk HPV among 902 women aged 20-59 yr and the seroprevalence of low-risk HPV subtypes 6 and 11 among 1,094 women aged 9-59 yr in the general population. Genital low-risk HPV DNA was assessed by liquid hybridization and polymerase chain reaction. Antibody titers against HPV 6 and 11 were measured by a multiplexed competitive luminex technique. The prevalence of genital low-risk HPV was 4.9%. It reached its highest peak of 10.3% at 20-29 yr of age and a second peak of 3.2% at 50-59 yr of age. The seroprevalence of HPV 6 or 11 was 9.4%. It reached its highest peak of 12.7% at 25-29 yr of age and a second peak of 12.3% at 50-59 yr of age. In multivariable analysis, the number of lifetime sexual partners and past history of sexually transmitted diseases were associated with the seroprevalence but not prevalence of HPV. It is suggested that younger women should receive prophylactic HPV vaccination before they become sexually active and exposed to HPV in their 20s. This study provides baseline data for developing HPV vaccination programs and monitoring vaccine efficacy in Korea.

摘要

关于韩国女性中低危型人乳头瘤病毒(HPV)的流行率和血清流行率以及 HPV 感染的危险因素,人们知之甚少。我们确定了 902 名 20-59 岁女性中低危型 HPV 的流行率,以及 1094 名 9-59 岁女性中低危型 HPV 亚型 6 和 11 的血清流行率。通过液体杂交和聚合酶链反应评估生殖道低危型 HPV DNA。通过多重竞争 Luminex 技术测量针对 HPV 6 和 11 的抗体滴度。生殖道低危型 HPV 的流行率为 4.9%。它在 20-29 岁年龄组达到最高峰值 10.3%,在 50-59 岁年龄组达到第二个峰值 3.2%。HPV 6 或 11 的血清流行率为 9.4%。它在 25-29 岁年龄组达到最高峰值 12.7%,在 50-59 岁年龄组达到第二个峰值 12.3%。在多变量分析中,性伴侣人数和性传播疾病史与 HPV 血清流行率有关,但与 HPV 流行率无关。建议年轻女性在 20 多岁开始性行为并接触 HPV 之前接受预防性 HPV 疫苗接种。本研究为在韩国制定 HPV 疫苗接种计划和监测疫苗效果提供了基线数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/3410241/bc202223c12c/jkms-27-922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/3410241/bc202223c12c/jkms-27-922-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f707/3410241/bc202223c12c/jkms-27-922-g001.jpg

相似文献

1
Prevalence and seroprevalence of low-risk human papillomavirus in Korean women.韩国女性中低危型人乳头瘤病毒的流行率和血清流行率。
J Korean Med Sci. 2012 Aug;27(8):922-8. doi: 10.3346/jkms.2012.27.8.922. Epub 2012 Jul 25.
2
Prevalence and seroprevalence of high-risk human papillomavirus infection.高危型人乳头瘤病毒感染的流行率和血清阳性率。
Obstet Gynecol. 2010 Oct;116(4):932-940. doi: 10.1097/AOG.0b013e3181edbeba.
3
Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.中国女性人乳头瘤病毒 6、11、16 和 18 型的血清流行率。
BMC Infect Dis. 2012 Jun 20;12:137. doi: 10.1186/1471-2334-12-137.
4
Prevalence of human papillomavirus antibodies in males and females in England.英格兰男女性别中人乳头瘤病毒抗体的流行情况。
Sex Transm Dis. 2011 Jul;38(7):622-9. doi: 10.1097/OLQ.0b013e31820bc880.
5
Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.巴西圣保罗年轻初产妇人乳头瘤病毒 6、11、16 和 18 的血清流行率。
Int J Gynecol Cancer. 2010 Nov;20(8):1405-10. doi: 10.1111/IGC.0b013e3181f3c85e.
6
Genital Wart and Human Papillomavirus Prevalence in Men in the United States From Penile Swabs: Results From National Health and Nutrition Examination Surveys.美国男性生殖器疣和人乳头瘤病毒流行率:来自全国健康和营养检查调查的阴茎拭子结果。
Sex Transm Dis. 2018 Jun;45(6):412-416. doi: 10.1097/OLQ.0000000000000761.
7
Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.挪威年轻女性人乳头瘤病毒 6、11、16 和 18 感染的发生率及预测因素。
Sex Transm Dis. 2011 Jul;38(7):587-97. doi: 10.1097/OLQ.0b013e31820a9324.
8
A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.新疆维吾尔族女性中4种人乳头瘤病毒亚型抗体的血清学流行病学调查
Jpn J Infect Dis. 2016 Jul 22;69(4):273-8. doi: 10.7883/yoken.JJID.2015.154. Epub 2015 Aug 7.
9
Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.牙买加性病门诊就诊者中人乳头瘤病毒的流行情况:年龄较小与性活动增加之间的关联。
Sex Transm Dis. 1995 Mar-Apr;22(2):114-8. doi: 10.1097/00007435-199503000-00007.
10
Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.巴西 HIV 感染者和未感染者中 HPV 疫苗类型 6、11、16 和 18 的血清流行率。
J Clin Virol. 2013 Jun;57(2):147-51. doi: 10.1016/j.jcv.2013.02.007. Epub 2013 Mar 9.

引用本文的文献

1
Estimating the Burden of Illness Related to Genital Warts in Russia: A Cross-Sectional Study.俄罗斯生殖器疣相关疾病负担的估计:一项横断面研究。
J Health Econ Outcomes Res. 2020 Oct 7;7(2):182-188. doi: 10.36469/jheor.2020.17246. eCollection 2020.
2
Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study.菲律宾生殖器疣相关疾病负担的估计:一项全国代表性横断面研究。
Infect Agent Cancer. 2019 Oct 7;14:26. doi: 10.1186/s13027-019-0240-y. eCollection 2019.
3
Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection.

本文引用的文献

1
Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus.韩国系统性红斑狼疮女性中人类乳头瘤病毒感染和宫颈细胞学异常的流行情况。
J Korean Med Sci. 2010 Oct;25(10):1431-7. doi: 10.3346/jkms.2010.25.10.1431. Epub 2010 Sep 17.
2
Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years.10-14 岁韩国女童接种 HPV-16/18 AS04 佐剂宫颈癌疫苗。
J Korean Med Sci. 2010 Aug;25(8):1197-204. doi: 10.3346/jkms.2010.25.8.1197. Epub 2010 Jul 21.
3
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
基于组织的代谢组学揭示了宫颈癌和 HPV 感染的潜在生物标志物。
Bosn J Basic Med Sci. 2020 Feb 5;20(1):78-87. doi: 10.17305/bjbms.2019.4359.
4
Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea.一项横断面研究,评估韩国尖锐湿疣及其他肛门生殖器疾病的心理社会影响。
BMJ Open. 2019 Mar 20;9(3):e025035. doi: 10.1136/bmjopen-2018-025035.
5
A cross-sectional study estimating the burden of illness related to genital warts in South Korea.一项估算韩国尖锐湿疣相关疾病负担的横断面研究。
BMJ Open. 2017 Jul 2;7(6):e014217. doi: 10.1136/bmjopen-2016-014217.
6
Candidates for tumor markers of cervical cancer discovered by proteomic analysis.蛋白质组分析发现的宫颈癌肿瘤标志物候选物。
J Korean Med Sci. 2012 Dec;27(12):1479-85. doi: 10.3346/jkms.2012.27.12.1479. Epub 2012 Dec 7.
美国6型、11型、16型和18型人乳头瘤病毒血清流行率:2003 - 2004年国家健康和营养检查调查
J Infect Dis. 2009 Oct 1;200(7):1059-67. doi: 10.1086/604729.
4
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.24至45岁女性四价人乳头瘤病毒(6、11、16、18型)重组疫苗的安全性、免疫原性及有效性:一项随机双盲试验
Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.
5
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.细胞学正常女性中宫颈人乳头瘤病毒感染的患病率、感染情况及清除情况:夏威夷人乳头瘤病毒队列研究
Cancer Res. 2008 Nov 1;68(21):8813-24. doi: 10.1158/0008-5472.CAN-08-1380.
6
Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.澳大利亚男性、女性和儿童中6型、11型、16型和18型人乳头瘤病毒的人群血清阳性率
Clin Infect Dis. 2008 Jun 1;46(11):1647-55. doi: 10.1086/587895.
7
Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994.美国11型人乳头瘤病毒血清流行病学:1991年至1994年第三次全国健康和营养检查调查结果
Sex Transm Dis. 2008 Mar;35(3):298-303. doi: 10.1097/OLQ.0b013e31815abaef.
8
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.挪威年轻女性队列中6、11、16和18型人乳头瘤病毒的血清流行率和生殖器DNA流行率:研究设计与队列特征
Acta Obstet Gynecol Scand. 2008;87(1):81-8. doi: 10.1080/00016340701714703.
9
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.韩国釜山男女大学生对致癌性人乳头瘤病毒各型的血清学反应
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1874-9. doi: 10.1158/1055-9965.EPI-07-0349.
10
Prevalence of HPV infection among females in the United States.美国女性人乳头瘤病毒(HPV)感染率
JAMA. 2007 Feb 28;297(8):813-9. doi: 10.1001/jama.297.8.813.